Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""T cells"" wg kryterium: Temat


Starter badań:

Tytuł :
The role of unconventional T cells in COVID-19.
Autorzy :
Orumaa K; Department of Clinical Microbiology and Department of Immunology, Trinity Translational Medicine Institute, St James's Hospital, Dublin 8, Ireland.
Dunne MR; Department of Clinical Microbiology and Department of Immunology, Trinity Translational Medicine Institute, St James's Hospital, Dublin 8, Ireland. .
Pokaż więcej
Źródło :
Irish journal of medical science [Ir J Med Sci] 2022 Apr; Vol. 191 (2), pp. 519-528. Date of Electronic Publication: 2021 May 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*
Mucosal-Associated Invariant T Cells*
Natural Killer T-Cells*
Humans ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Differential location of NKT and MAIT cells within lymphoid tissue.
Autorzy :
Johnson DN; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Ruan Z; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.
Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.
Devi S; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Holz LE; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Uldrich AP; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Mak JYW; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.
Hor JL; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Mueller SN; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
McCluskey J; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Fairlie DP; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.
Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, 3010, Australia.
Heath WR; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia.; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia.
Godfrey DI; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3010, Australia. .; Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Parkville, VIC, 3010, Australia. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Mar 08; Vol. 12 (1), pp. 4034. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphoid Tissue*/metabolism
Mucosal-Associated Invariant T Cells*/metabolism
Natural Killer T-Cells*/metabolism
Animals ; Mice ; Mice, Transgenic ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Antigen, T-Cell, alpha-beta/genetics ; Receptors, Antigen, T-Cell, alpha-beta/metabolism
Czasopismo naukowe
Tytuł :
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
Autorzy :
Du Y; Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Khera T; Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Strunz B; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Deterding K; Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Todt D; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.; European Virus Bioinformatics Center (EVBC), Jena, Germany.
Woller N; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Engelskircher SA; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Hardtke S; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), HepNet Study-House, Hannover, Germany.
Port K; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Ponzetta A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Steinmann E; Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Cornberg M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), HepNet Study-House, Hannover, Germany.; Center for Individualized Infection Medicine (CIIM), Hannover, Germany.; Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.; Cluster of Excellence Resolving Infection Susceptibility (RESIST: EXC), Hannover Medical School, Hannover, Germany.
Hengst J; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Björkström NK; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Wedemeyer H; Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), HepNet Study-House, Hannover, Germany.
Pokaż więcej
Corporate Authors :
HepNet Acute HCV Ⅳ Study Group; Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Źródło :
European journal of immunology [Eur J Immunol] 2022 Mar; Vol. 52 (3), pp. 472-483. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C, Chronic*
Mucosal-Associated Invariant T Cells*
Antiviral Agents/therapeutic use ; CD8-Positive T-Lymphocytes ; Hepacivirus ; Humans
Czasopismo naukowe
Tytuł :
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.
Autorzy :
Boulouis C; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Kammann T; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Cuapio A; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Parrot T; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Gao Y; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Mouchtaridi E; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Wullimann D; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Lange J; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Chen P; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Akber M; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Rivera Ballesteros O; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Muvva JR; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Smith CIE; Department of Laboratory Medicine, Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.; Department of Laboratory Medicine, Translational Research Center Karolinska (TRACK), Karolinska Institutet, Stockholm, Sweden.
Vesterbacka J; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Huddinge, Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
Kieri O; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Huddinge, Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
Nowak P; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Huddinge, Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
Bergman P; Department of Laboratory Medicine, Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Buggert M; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Ljunggren HG; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden.
Aleman S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine Huddinge, Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
Sandberg JK; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, 14152, Stockholm, Sweden. .
Pokaż więcej
Corporate Authors :
COVAXID study group
Źródło :
Molecular medicine (Cambridge, Mass.) [Mol Med] 2022 May 13; Vol. 28 (1), pp. 54. Date of Electronic Publication: 2022 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/prevention & control
Mucosal-Associated Invariant T Cells*
BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; Immunity, Humoral ; RNA, Messenger/genetics ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Vaccines, Synthetic ; mRNA Vaccines
Czasopismo naukowe
Tytuł :
Elevated circulating memory T cells precede immunotherapy toxicities in melanoma.
Autorzy :
Bello E; UMass Chan Medical School, Worcester, MA, USA.
Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: .
Pokaż więcej
Źródło :
Trends in cancer [Trends Cancer] 2022 May; Vol. 8 (5), pp. 347-349. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Melanoma*/drug therapy
Memory T Cells*
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Immunotherapy/adverse effects
Czasopismo naukowe
Tytuł :
Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial.
Autorzy :
Cheng X; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China; Clinical Research Center, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200011, P.R. China.
Wang J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Qiu C; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Jin Y; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Xia B; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Qin R; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Hu H; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Yan J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China.
Zhang X; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China. Electronic address: .
Xu J; Shanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Fudan University, Shanghai 201508, P.R. China. Electronic address: .
Pokaż więcej
Źródło :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 May; Vol. 238, pp. 108992. Date of Electronic Publication: 2022 Mar 30.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms :
Adenocarcinoma of Lung*
Antineoplastic Agents, Immunological*/therapeutic use
Lung Neoplasms*/drug therapy
Natural Killer T-Cells*/pathology
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; CD8-Positive T-Lymphocytes/pathology ; Feasibility Studies ; Humans ; Immunologic Factors/therapeutic use ; Immunotherapy ; Programmed Cell Death 1 Receptor
Czasopismo naukowe
Tytuł :
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
Autorzy :
Tarke A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Internal Medicine and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa 16132, Italy.
Coelho CH; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Zhang Z; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Dan JM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.
Yu ED; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Methot N; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Bloom NI; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Goodwin B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Phillips E; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Mallal S; Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Sidney J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Filaci G; Department of Internal Medicine and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa 16132, Italy; Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, Genoa 16132, Italy.
Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
da Silva Antunes R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
Crotty S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA. Electronic address: .
Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA. Electronic address: .
Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2022 Mar 03; Vol. 185 (5), pp. 847-859.e11. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines/*immunology
Memory B Cells/*immunology
Memory T Cells/*immunology
SARS-CoV-2/*immunology
Ad26COVS1/administration & dosage ; Ad26COVS1/immunology ; BNT162 Vaccine/administration & dosage ; BNT162 Vaccine/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; COVID-19/pathology ; COVID-19/prevention & control ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; Epitopes/immunology ; Epitopes, T-Lymphocyte/immunology ; Humans ; Memory B Cells/metabolism ; Memory T Cells/metabolism ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/metabolism ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology ; Vaccination
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
Autorzy :
Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Saini NY; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Cha SC; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Wang Z; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Stadtmauer EA; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Baladandayuthapani V; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
Tross B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Honhar M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Rao SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kim K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Popescu M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Szymura S; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Zhang T; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Anderson A; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Levine BL; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Kerr N; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Garfall A; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Cohen A; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Vogl DT; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Dengel K; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
June CH; Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Kwak LW; Toni Stephenson Lymphoma Center, Hematologic Malignancies Research Institute, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Pokaż więcej
Źródło :
Blood [Blood] 2022 Mar 03; Vol. 139 (9), pp. 1289-1301.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Adoptive Transfer*
CD4-Positive T-Lymphocytes*/immunology
CD4-Positive T-Lymphocytes*/transplantation
CD8-Positive T-Lymphocytes*/immunology
CD8-Positive T-Lymphocytes*/transplantation
Memory T Cells*/immunology
Memory T Cells*/transplantation
Multiple Myeloma*/immunology
Multiple Myeloma*/mortality
Multiple Myeloma*/therapy
Vaccination*
Cancer Vaccines/*administration & dosage
Autografts ; Cancer Vaccines/immunology ; Disease-Free Survival ; Female ; Hemocyanins/administration & dosage ; Hemocyanins/immunology ; Humans ; Male ; Survival Rate ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression.
Autorzy :
Nelson A; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada.
Gebremeskel S; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada.
Lichty BD; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Johnston B; Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada .; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Pancreatic Ductal*/therapy
Natural Killer T-Cells*
Oncolytic Virotherapy*/methods
Oncolytic Viruses*
Pancreatic Neoplasms*/therapy
Animals ; Cell Line, Tumor ; Cytokines/metabolism ; Humans ; Immunotherapy ; Interleukin-15/genetics ; Interleukin-15/metabolism ; Mice ; Mice, Inbred C57BL ; Programmed Cell Death 1 Receptor/metabolism ; Vesicular stomatitis Indiana virus/metabolism ; Vesiculovirus
SCR Disease Name :
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł :
A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
Autorzy :
Wang GN; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Zhao WG; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Zhang XD; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Jian XY; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Zhang CL; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Zhang MZ; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China. .
Li WC; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 May 03; Vol. 12 (1), pp. 7118. Date of Electronic Publication: 2022 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Extranodal NK-T-Cell*/diagnosis
Natural Killer T-Cells*/pathology
Adolescent ; Adult ; Child ; Female ; Humans ; Ki-1 Antigen ; Killer Cells, Natural/pathology ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function.
Autorzy :
Wenes M; Department of Oncology, University of Lausanne, Épalinges, Switzerland. Electronic address: .
Jaccard A; Department of Oncology, University of Lausanne, Épalinges, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Épalinges, Switzerland.
Wyss T; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Maldonado-Pérez N; Gene and Cell Therapy Unit, Genomic Medicine Department, Pfizer-University of Granada-Junta de Andalucía, Centre for Genomics and Oncological Research (GENYO), Granada, Spain.
Teoh ST; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.
Lepez A; Brain Tumor and Immune Cell Engineering Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Renaud F; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Franco F; Department of Oncology, University of Lausanne, Épalinges, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Épalinges, Switzerland.
Waridel P; Protein Analysis Facility, University of Lausanne, Lausanne, Switzerland.
Yacoub Maroun C; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Tschumi B; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Dumauthioz N; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Zhang L; Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China; Suzhou Institute of Systems Medicine, Suzhou 215123, China.
Donda A; Department of Oncology, University of Lausanne, Épalinges, Switzerland.
Martín F; Gene and Cell Therapy Unit, Genomic Medicine Department, Pfizer-University of Granada-Junta de Andalucía, Centre for Genomics and Oncological Research (GENYO), Granada, Spain.
Migliorini D; Brain Tumor and Immune Cell Engineering Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland; Department of Oncology, Geneva University Hospitals (HUG), Geneva, Switzerland.
Lunt SY; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA; Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA.
Ho PC; Department of Oncology, University of Lausanne, Épalinges, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Épalinges, Switzerland.
Romero P; Department of Oncology, University of Lausanne, Épalinges, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Cell metabolism [Cell Metab] 2022 May 03; Vol. 34 (5), pp. 731-746.e9. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Memory T Cells*
Monocarboxylic Acid Transporters*/genetics
Monocarboxylic Acid Transporters*/metabolism
Lactates ; Mitochondria/metabolism ; Mitochondrial Membrane Transport Proteins/metabolism ; Pyruvic Acid/metabolism
Czasopismo naukowe
Tytuł :
Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.
Autorzy :
Wen X; Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Sichuan 646000, P.R. China. Electronic address: .
Nian S; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Wei G; Department of Cardiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, 646000, China. Electronic address: .
Kang P; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Yang Y; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Li L; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Ye Y; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Zhang L; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Wang S; Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China. Electronic address: .
Yuan Q; Public Center of Experimental Technology, Immune Mechanism and Therapy of Major Diseases of Luzhou Key Laboratory, the School of Basic Medical Science of Southwest Medical University, Luzhou, Sichuan 646000, China. Electronic address: .
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2022 May; Vol. 106, pp. 108606. Date of Electronic Publication: 2022 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Asthma*
Mucosal-Associated Invariant T Cells*
Cytokines/metabolism ; Humans ; Lymphocyte Activation ; Phenotype ; Th17 Cells
Czasopismo naukowe
Tytuł :
iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis.
Autorzy :
Einhaus J; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Asteriti E; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Pecher AC; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Autoinflammatory Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Keppeler H; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Klein R; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Schneidawind C; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Henes J; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Autoinflammatory Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Schneidawind D; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: .
Pokaż więcej
Źródło :
Cytotherapy [Cytotherapy] 2022 May; Vol. 24 (5), pp. 482-488. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji :
Journal Article
MeSH Terms :
Natural Killer T-Cells*
Scleroderma, Systemic*/metabolism
Scleroderma, Systemic*/therapy
Cytokines/metabolism ; Humans ; Interleukin-6/metabolism ; Lipopolysaccharides ; Lymphocyte Activation
Czasopismo naukowe
Tytuł :
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma.
Autorzy :
Zimmer CL; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Filipovic I; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Cornillet M; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
O'Rourke CJ; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Berglin L; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Jansson H; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Sun D; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Strauss O; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Hertwig L; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Johansson H; Division of Transplantation Surgery, CLINTEC, Karolinka Institutet and Department of Transplantation, Karolinska University Hospital, Stockholm, Sweden.
von Seth E; Division of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.; Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Sparrelid E; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Dias J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Glaumann H; Department of Medicine, Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
Melum E; Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Ellis EC; Division of Transplantation Surgery, CLINTEC, Karolinka Institutet and Department of Transplantation, Karolinska University Hospital, Stockholm, Sweden.
Sandberg JK; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Andersen JB; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bergquist A; Division of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.; Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Björkström NK; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2022 May; Vol. 75 (5), pp. 1154-1168. Date of Electronic Publication: 2021 Dec 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bile Duct Neoplasms*/pathology
Bile Ducts, Extrahepatic*/pathology
Cholangiocarcinoma*/pathology
Mucosal-Associated Invariant T Cells*
Bile Ducts, Intrahepatic/pathology ; Humans ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
Autorzy :
Yao T; Department of Microbiology and Immunology, Western University, 1151 Richmond Street, London, ON, Canada.
Rudak PT; Department of Microbiology and Immunology, Western University, 1151 Richmond Street, London, ON, Canada.
Laumont CM; Deeley Research Centre, BC Cancer, Victoria, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Michaud AR; Department of Microbiology and Immunology, Western University, 1151 Richmond Street, London, ON, Canada.
Rashu R; Department of Microbiology and Immunology, Western University, 1151 Richmond Street, London, ON, Canada.
Knier NN; Department of Medical Biophysics, Western University, London, ON, Canada.; Robarts Research Institute, Western University, London, ON, Canada.
Foster PJ; Department of Medical Biophysics, Western University, London, ON, Canada.; Robarts Research Institute, Western University, London, ON, Canada.
McWilliam HEG; Department of Microbiology and Immunology, The Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Villadangos JA; Department of Microbiology and Immunology, The Peter Doherty Institute of Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
DiMattia GE; Department of Biochemistry, Western University, London, ON, Canada.; The Mary & John Knight Translational Ovarian Cancer Research Unit, London, ON, Canada.; Department of Oncology, Western University, London, ON, Canada.; Department of Obstetrics and Gynaecology, Western University, London, ON, Canada.; London Regional Cancer Program, London, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.
Shepherd TG; The Mary & John Knight Translational Ovarian Cancer Research Unit, London, ON, Canada.; Department of Oncology, Western University, London, ON, Canada.; Department of Obstetrics and Gynaecology, Western University, London, ON, Canada.; London Regional Cancer Program, London, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Anatomy and Cell Biology, Western University, London, ON, Canada.
Haeryfar SMM; Department of Microbiology and Immunology, Western University, 1151 Richmond Street, London, ON, Canada. .; Lawson Health Research Institute, London, ON, Canada. .; Centre for Human Immunology, Western University, London, ON, Canada. .; Department of Surgery, Division of General Surgery, Western University, London, ON, Canada. .; Department of Medicine, Division of Clinical Immunology and Allergy, Western University, London, ON, Canada. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 May; Vol. 71 (5), pp. 1259-1273. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji :
Journal Article
MeSH Terms :
Mucosal-Associated Invariant T Cells*
Ovarian Neoplasms*
Animals ; Ascites ; CD8-Positive T-Lymphocytes ; Carcinoma, Ovarian Epithelial ; Cues ; Cytokines ; Female ; Histocompatibility Antigens Class I/genetics ; Humans ; Interleukin-17 ; Ligands ; Mice ; Minor Histocompatibility Antigens
Czasopismo naukowe
Tytuł :
Intrahepatic microbes govern liver immunity by programming NKT cells.
Autorzy :
Leinwand JC; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Paul B; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Chen R; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Xu F; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Sierra MA; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Paluru MM; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Nanduri S; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Alcantara CG; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Shadaloey SA; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Yang F; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Adam SA; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Li Q; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Bandel M; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Gakhal I; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Appiah L; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Guo Y; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Vardhan M; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Flaminio Z; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Grodman ER; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Mermelstein A; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Wang W; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Diskin B; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Aykut B; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Khan M; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Werba G; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Pushalkar S; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
McKinstry M; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Kluger Z; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Park JJ; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.
Hsieh B; Department of Pathology.; Department of Medicine.; Ronald O. Perelman Department of Dermatology, and.
Dancel-Manning K; Department of Cell Biology, NYU Langone Health, New York, New York, USA.
Liang FX; Department of Cell Biology, NYU Langone Health, New York, New York, USA.
Park JS; Department of Medicine.
Saxena A; Biology Department, Brooklyn College and Biology/Biochemistry Programs, Graduate Center (CUNY), New York, New York, USA.
Li X; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Theise ND; Department of Pathology.
Saxena D; Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York, USA.
Miller G; S.A. Localio Laboratory, Department of Surgery, New York University (NYU) Langone Health, New York, New York, USA.; Department of Cell Biology, NYU Langone Health, New York, New York, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2022 Apr 15; Vol. 132 (8).
Typ publikacji :
Journal Article
MeSH Terms :
Gastrointestinal Microbiome*
Natural Killer T-Cells*
Adaptive Immunity ; Animals ; Feces/microbiology ; Liver ; Mice
Czasopismo naukowe
Tytuł :
Tissue resident memory T cells inhabit the deep human conjunctiva.
Autorzy :
Arnous R; Centre for Vision Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Arshad S; Centre for Vision Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Sandgren K; Centre for Virus Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Cunningham AL; Centre for Virus Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Carnt N; Centre for Vision Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia.; School of Optometry and Vision Science, University of New South Wales, Kensington, NSW, 2033, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
White A; Centre for Vision Research, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia. .; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia. .; Save Sight Institute, The University of Sydney, Sydney, NSW, 2000, Australia. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2022 Apr 12; Vol. 12 (1), pp. 6077. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji :
Journal Article
MeSH Terms :
Immunologic Memory*
Memory T Cells*
Adult ; Aged ; CD8-Positive T-Lymphocytes ; Conjunctiva ; Epithelium ; Female ; Humans ; Middle Aged ; Mucous Membrane
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies